Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2022, 4(3); doi: 10.25236/FMSR.2022.040308.

Research Progress of TCM Treatment of Hysteromyoma

Author(s)

Jiahui He

Corresponding Author:
Jiahui He
Affiliation(s)

Department of Chinese Medicine, Zhuji People's Hospital of Zhejiang Province, Zhuji, China

Abstract

Hysteromyoma is a common disease that is difficult to cure in gynecology. In recent years, the incidence rate of hysteromyoma has gradually increased and Hysteromyoma patients are getting younger. Traditional Chinese Medicine (TCM) has the advantages of significant curative effect, appropriate price and no trauma. By exploring the modern medical research, etiology, pathogenesis and treatment of TCM, this paper hopes to contribute to the clinical treatment of this disease.

Keywords

Hysteromyoma; TCM; Research progress

Cite This Paper

Jiahui He. Research Progress of TCM Treatment of Hysteromyoma. Frontiers in Medical Science Research (2022) Vol. 4, Issue 3: 43-46. https://doi.org/10.25236/FMSR.2022.040308.

References

[1] Teng Hong. Effectiveness evaluation of Gongliuxiao capsule combined with mifepristone in the treatment of uterine fibroids [J]. Guide of china medicine, 2021,19(31) :16-18 . DOI:10.15912/j.cnki.gocm.2021.31.006.

[2] Xu Ning, Wang Xiaobao. Expression levels of miR-18a in uterine fibroid tissues and the relationship with sex hormone levels and endometrial tolerance [J]. China Women and Children Health Care, 2021,36(21):5056-5058.DOI:10.19829/j.zgfybj.issn.1001-4411.2021.21.052.

[3] Weinije Tursun, Nilofa Settiwaldi. Progress of research on the etiology and treatment of uterine fibroids in traditional Chinese medicine (VCM) [J]. Smart Health, 2021,7(10):37-39. DOI:10.19335/j.cnki.2096-1219.2021.10.013.

[4] Tang Xiaoxia, Hou Cui, Zhang Wanlu, Zeng Yanhua, Yang Zhihong. The relationship between uterine fibroids and polymorphism of estrogen metabolizing enzymes CYP1A1 and COMT genes [J]. Chinese Medical Records, 2020,21(05):86-89.

[5] Wu Juan, Zhang Ziyu, Zou Yang, Luo Yong, Huang Oping. Effects of high-frequency mutation of MED12 on cell proliferation, invasion, migration and apoptosis in patients with uterine leiomyoma [J]. progress in obstetrics and gynecology, 2018, 27(02): 112-114. DOI:10.13283/j.cnki.xdfckjz.2018.02.007.

[6] Mao Huijuan, Huang Guoqin, Ming Jing, Shi Yaqin. Analysis of correlation between occurrence of uterine myoma and insulin-like growth factor -1 and metabolic syndrome [J]. Modern Medicine and Health, 2021,37(21):3691-3694.

[7] Xing Yan, Cui Li’ning. Controlled evaluation of the effects of myomectomy and hysterectomy on ovarian function in patients with uterine fibroids [J]. Chinese primary medicine, 2018, 25(3):348-351.

[8] Zhao Na, Li Xi, Huo Zhuhui, Zhao Jufen. Comparison of the efficacy of laparoscopic myomectomy and traditional laparotomy myomectomy in the treatment of uterine fibroids [J]. Yunnan Medicine, 2021,42(05):451-452.

[9] Shi Shasha, Yu Chenghao. Progress in the treatment of uterine fibroids [J]. Women and Children Health Care, 2020,35 (16): 3122-3125. DOI: 10.19829/J. ZGFYBJ. ISSN.1001-4411.2020.16.060. 

[10] Chen Yujie, Liu Guohong. Research status of conservative treatment of uterine fibroids in western medicine [J]. Electronic Journal of Modern Medicine and Health Research, 2020,4(14):108-111. 

[11] Shen Lei, Zhang Tianchan, Cong Huifang, Chen Xue, Wang Tingting. Experience summary of Professor Cong Huifang on treatment of uterine fibroids from liver [J]. Asia-Pacific Traditional Medicine, 2018,14(01):125-126. 

[12] Wang Qiao, Zhang Zhenzhen, Wan Guiping. Study on the application of Guizhi Fuling Pill in the treatment of uterine fibroids [J]. Journal of Traditional Chinese Medicine Oncology, 2021, 3 (05): 52-57. DOI: 10.19811/j. CN Ki. ISSN 2096-6628.2021.05.012.

[13] Zeng Weijing. Clinical observation on the treatment of uterine fibroids with the method of activating blood and resolving stasis [J]. Guangming TCM, 2021, 36(13):2207-2209. 

[14] CAI Hui, Liu Yi, Xu Jingjing. Effects of traditional Chinese medicine (TCM) for nourishing, regulating and removing blood stasis on the expression levels of vascular endothelial growth factor receptor and estrogen and progesterone receptor in the tissues of patients with uterine fibroids and on the mechanism of action in cell proliferation [J]. World Journal of Integrated Traditional Chinese and Western Medicine, 2021, 16 (06): 1063-1067. DOI: 10.13935/j. CN Ki. SJZX.210616. 

[15] Gao Jing, Huang Shenyi, Lin Jiating, Fu Wenbin, Ning Baile. Clinical experience of the integration of acupuncture and moxibustion therapy of "one needle two moxibustion and three consolidation" in the treatment of uterine leiomyomatosis [J]. Global Chinese Medicine, 2020, 13(09):1592-1594. 

[16] Liu Erlan. Clinical observation of acupoint catgut embedding in the treatment of abdominal mass due to qi stagnation and blood stasis [J]. China Continuing Medical Education, 2018, 10(9):128-129. 

[17] Liu Hui. Application of He's fire needle in uterine fibroids and its mechanism discussion [J]. Journal of External Chinese Medicine, 2016,25(3):37 

[18] Qin Wenping, Peng Liying, Niu Yanli, Zhang Lijun. Observation on the efficacy of internal and external use of traditional Chinese medicine in the treatment of 122 cases of uterine fibroids [J]. Hebei journal of traditional Chinese medicine, 2010,32(07):1005-1006.